Flortaucipir f 18 Uses, Dosage, Side Effects and more
Flortaucipir f 18 is under investigation in clinical trial NCT03507257 (Longitudinal Early-onset Alzheimer's Disease Study Protocol).
| Attribute | Details |
|---|---|
| Trade Name | Flortaucipir f 18 |
| Generic | Flortaucipir |
| Type | Intravenous |
| Formula | C16H10FN3 |
| Weight | Average: 263.275 Monoisotopic: 263.085875497 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | United States |
| Last Updated: | January 7, 2025 at 1:49 am |
